MyFinsight
Home
Blog
About
Contact
Back
Income Statement
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT)
source: myfinsight.com
Download
Download image
Net loss
attributable to common...
-$1,290,454
(-13.19%↓ Y/Y)
Net loss
attributable to...
-$10,495
(51.17%↑ Y/Y)
Net loss
-$1,300,949
(-12.00%↓ Y/Y)
Total operating loss
-$1,247,903
(-13.66%↓ Y/Y)
Interest expense
$53,046
(183.33%↑ Y/Y)
Total operating
expenses
$1,247,903
(-9.35%↓ Y/Y)
General and
administrative
$914,569
(-7.41%↓ Y/Y)
Research and development
$333,334
(-14.27%↓ Y/Y)
Back